CureVac NV banner

CureVac NV
XBER:5CV

Watchlist Manager
CureVac NV Logo
CureVac NV
XBER:5CV
Watchlist
Price: 0.311 EUR Market Closed
Market Cap: €58m

Wall St Price Targets

5CV Price Targets Summary
CureVac NV

There are no price targets for 5CV.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
CureVac NV Competitors:
Price Targets
WLFC
Willis Lease Finance Corp
11% Upside
MTLS
Materialise NV
55% Upside
ZNTL
Zentalis Pharmaceuticals Inc
62% Upside
PGEN
Precigen Inc
136% Upside
CREX
Creative Realities Inc
175% Upside

Revenue
Forecast

98% / Year
Past Growth
-22% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
98% / Year
Past Growth
-22% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 5 years, the compound annual growth rate for Revenue has been 98%. The projected CAGR for the next 4 years is -22%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

N/A
Past Growth
-27% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
N/A
Past Growth
-27% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

The compound annual growth rate for Operating Income over the next 4 years is -27%.

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5CV's stock price target?
Not Available

5CV does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for CureVac NV?
Projected CAGR
-22%

Over the last 5 years, the compound annual growth rate for Revenue has been 98%. The projected CAGR for the next 4 years is -22%.

What is the Operating Income forecast for CureVac NV?
Projected CAGR
-27%

The compound annual growth rate for Operating Income over the next 4 years is -27%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett